| Income Statement |
| Total Revenue | 17.72M |
|
| Revenues (USD) | 17.72M |
| Cost of Revenue | 11.53M |
| Gross Profit | 6.19M |
| Operating Expenses | 5.40M |
| Research and Development Expense | -407.00K |
| Selling, General and Administrative Expense | 2.19M |
| Operating Income | 788.00K |
| Interest Expense | 384.00K |
| Net Income | 305.00K |
| Net Income Common Stock | 305.00K |
| Net Income Common Stock (USD) | 305.00K |
| Consolidated Income | 305.00K |
| Earnings per Basic Share | 0.01 |
| Earnings per Basic Share (USD) | 0.01 |
| Earnings per Diluted Share | 0.01 |
| Earning Before Interest & Taxes (EBIT) | 689.00K |
| Earning Before Interest & Taxes (USD) | 689.00K |
| Weighted Average Shares | 49.74M |
| Weighted Average Shares Diluted | 52.50M |
| Balance Sheet |
| Cash and Equivalents | 16.25M |
| Cash and Equivalents (USD) | 16.25M |
| Trade and Non-Trade Receivables | 29.98M |
| Current Assets | 75.96M |
| Property, Plant & Equipment Net | 19.04M |
| Total Assets | 118.52M |
| Debt Current | 777.00K |
| Total Debt | 41.06M |
| Current Liabilities | 10.08M |
| Debt Non-Current | 40.28M |
| Total Liabilities | 51.29M |
| Accumulated Retained Earnings (Deficit) | -123.52M |
| Accumulated Other Comprehensive Income | 6.24M |
| Shareholders Equity | 67.23M |
| Shareholders Equity (USD) | 67.23M |
| Assets Non-Current | 42.56M |
| Total Debt (USD) | 41.06M |
| Inventory | 18.27M |
| Liabilities Non-Current | 41.20M |
| Trade and Non-Trade Payables | 9.69M |
| Tax Assets | 2.17M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 500.00K |
| Net Cash Flow from Financing | 7.52M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -6.44M |
| Capital Expenditure | -2.58M |
| Issuance (Purchase) of Equity Shares | 1.58M |
| Issuance (Repayment) of Debt Securities | 5.94M |
| Net Cash Flow from Investing | -2.59M |
| Net Cash Flow from Operations | 4.24M |
| Effect of Exchange Rate Changes on Cash | -412.00K |
| Share Based Compensation | 2.38M |